Search for: "WYETH PHARMACEUTICALS COMPANY" Results 481 - 500 of 547
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
19 Sep 2013, 9:53 am by Bexis
  By itself, off-label promotion is no more causal than, as we commented the other day, a “video of a company employee kicking his dog. [read post]
18 Oct 2007, 10:33 pm
The trial court ignored the FDA's position and the company sought mandamus. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
16 Aug 2009, 11:23 am
Given that the shell company was without resources, sellers were put in the position of relying on the reputational risk to the private equity firm if its wholly owned shell company breached its obligations as well as the possibility of veil piercing. [read post]
23 May 2019, 9:30 pm by Alana Bevan
Supreme Court ruled that judges rather than juries should determine whether or not pharmaceutical product liability claims may proceed under the “clear evidence” standard established in Wyeth v. [read post]
31 Oct 2011, 4:58 am by Max Kennerly, Esq.
When a plaintiff’s lawyer is considering filing dozens or hundreds of lawsuits against GlaxoSmithKline, or AstraZeneca, or Teva Pharmaceuticals, or Siemens Medical, or McNeil Laboratories, or Merck, or Wyeth — all of which have a significant presence in or around Philadelphia — the obvious choice is to file in the quicker venue with more experience and more resources to handle the cases. [read post]
25 Sep 2007, 1:00 am
HRT Patient's Personal Injury Claim Found to Be Time-Barred The Legal Intelligencer A woman who sued Wyeth Pharmaceuticals, claiming that the hormone replacement therapy she took was the cause of her breast cancer, is barred by the two-year statute of limitations from bringing a personal injury claim, a Philadelphia Common Pleas judge ruled Monday. [read post]
6 Sep 2010, 10:21 am by Steve McConnell
Novartis Pharmaceuticals Corp., 2010 U.S. [read post]
31 Jan 2008, 8:20 am
While Gourdine's probably not all that big of a deal now, with the Supreme Court having agreed to decide Wyeth v. [read post]
16 Apr 2007, 3:04 am
Defendant pharmaceutical company Wyeth's appeal of the judgment was noteworthy because it would have tested Texas' statutory cap limiting punitive damages. [read post]
4 May 2010, 11:32 am by Steve Bainbridge
In recent days, offers of help have come from such         companies as Anheuser-Busch and Culligan (water), Lilly, Merck and Wyeth         (pharmaceuticals), Nissan and GM (cars and trucks), Sprint, Nextel and         Qwest (communications gear and phone cards), Johnson &… [read post]
29 May 2009, 1:28 am
The settlement comes about 10 days after the DOJ announced it would join whistleblower lawsuits against pharmaceutical giant Wyeth. [read post]